The evaluation of the economic burden caused by delay in the diagnosis and treatment for patients with diabetes mellitus based on Japanese Medical Big Data_Chinese Journal of Evidence-Based Medicine

Authors：

 TANG Wentao , IWASAKI Kosuke

Milliman Inc., Tokyo, 102-0083, Japan;

Corresponding author：

TANG Wentao, Email: twtreaher@gmail.com

Keywords：

Diabetes mellitus; Delayed diagnosis; Health care costs; Health policy; Delayed treatment; Health insurance; Japan

DOI：

10.7507/1672-2531.201808139

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To analyze the economic burden caused by delay in the diagnosis and treatment of diabetes.Methods The employee/non-employee health insurance and medical examination data from Japan Medical Data Center (JMDC) and Milliman Inc. were used to analyze the health economic burden of the situation in case the diabetic population receives timelydiagnosis and treatment with real world data.Results The overall population delaying the diabetes diagnosis and treatment in Japan was estimated to be 916 000, and the average time of delay was 39.6 months. The increase in time of delay was related with the increase in monthly medical costs after diabetes diagnosis. If the whole delayed population could receive timely diagnosis and treatment, it can totally save about 38.24 billion yuan (1.5% of the annual Japanese national medical expenditure.Conclusions The current study suggests a huge potential health economic burden that can be improved by promoting the diagnosis and treatment of diabetes, which provides reference for the economic evaluation of similar health policies and also the application of real world data in China in future.

Citation： TANG Wentao, IWASAKI Kosuke. The evaluation of the economic burden caused by delay in the diagnosis and treatment for patients with diabetes mellitus based on Japanese Medical Big Data. Chinese Journal of Evidence-Based Medicine, 2019, 19(4): 392-397. doi: 10.7507/1672-2531.201808139 Copy

1.	Wu H, Eggleston KN, Zhong J, et al. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data. J Diabetes Investig, 2018, 11. In press.
2.	陈兴宝, 唐玲, 陈惠云, 等. 2型糖尿病并发症对患者治疗费用的影响评估. 中国糖尿病杂志, 2003, 11(4): 238-241.
3.	日本厚生劳动省. 平成28年国民健康和营养调查. Available at: https://www.mhlw.go.jp/stf/houdou/0000177189.html.
4.	Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24): 2515-2523.
5.	顾景范. 《中国居民营养与慢性病状况报告(2015)》解读. 营养学报, 2016, 38(6): 525-529.
6.	王蕊琪, 周郁秋, 贾红红. 糖尿病患者治疗延误行为意向的现象学研究. 护理学杂志, 2018, 3(33): 43-46.
7.	Japan Medical Data Center. JMDC Claims Database的特长. Available at: https://www.jmdc.co.jp/pharma/database.html.
8.	日本厚生劳动省. 平成24年版厚生劳动白书. Available at: https://www.mhlw.go.jp/wp/hakusyo/kousei/12-2/.
9.	World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation, 2011. Available at: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf.
10.	日本糖尿病学会. 糖尿病治疗指南2018～2019. Available at: http://www.jds.or.jp/modules/education/index.php?content_id=11.
11.	World Health Organization. ICD-10 online versions. Available at: http://www.who.int/classifications/icd/icdonlineversions/en/.
12.	WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2018. Available at: https://www.whocc.no/atc_ddd_index/.
13.	日本厚生劳动省. 平成29年版厚生劳动白书. Available at: https://www.mhlw.go.jp/wp/hakusyo/kousei/17-2/.
14.	日本厚生劳动省. 平成27年度国民医疗费的概况. Available at: https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/15/index.html.
15.	International Diabetes Federation. IDF diabetes atlas - 8th edition. Available at: http://www.diabetesatlas.org/across-the-globe.html.
16.	胡善联, 刘国恩, 许樟荣, 等. 我国糖尿病流行病学和疾病经济负担研究现状. 中国卫生经济, 2008, 27(8): 5-8.
17.	中国政府网. 2016年我国卫生和计划生育事业发展统计公报. Available at: http://www.nhfpc.gov.cn/guihuaxxs/s10748/201708/d82fa7141696407abb4ef764f3edf095.shtml?from=groupmessage&isappinstalled=1.
18.	Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care, 1992, 15(7): 815-8199.
19.	Porta M, Curletto G, Cipullo D, et al. Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence. Diabetes Care, 2014, 37(6): 1668-1674.
20.	Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in Primary Care (ADDITION-Europe). Diabetes Care, 2015, 38(8): 1449-1455.

1. Wu H, Eggleston KN, Zhong J, et al. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data. J Diabetes Investig, 2018, 11. In press.
2. 陈兴宝, 唐玲, 陈惠云, 等. 2型糖尿病并发症对患者治疗费用的影响评估. 中国糖尿病杂志, 2003, 11(4): 238-241.
3. 日本厚生劳动省. 平成28年国民健康和营养调查. Available at: https://www.mhlw.go.jp/stf/houdou/0000177189.html.
4. Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24): 2515-2523.
5. 顾景范. 《中国居民营养与慢性病状况报告(2015)》解读. 营养学报, 2016, 38(6): 525-529.
6. 王蕊琪, 周郁秋, 贾红红. 糖尿病患者治疗延误行为意向的现象学研究. 护理学杂志, 2018, 3(33): 43-46.
7. Japan Medical Data Center. JMDC Claims Database的特长. Available at: https://www.jmdc.co.jp/pharma/database.html.
8. 日本厚生劳动省. 平成24年版厚生劳动白书. Available at: https://www.mhlw.go.jp/wp/hakusyo/kousei/12-2/.
9. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation, 2011. Available at: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf.
10. 日本糖尿病学会. 糖尿病治疗指南2018～2019. Available at: http://www.jds.or.jp/modules/education/index.php?content_id=11.
11. World Health Organization. ICD-10 online versions. Available at: http://www.who.int/classifications/icd/icdonlineversions/en/.
12. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2018. Available at: https://www.whocc.no/atc_ddd_index/.
13. 日本厚生劳动省. 平成29年版厚生劳动白书. Available at: https://www.mhlw.go.jp/wp/hakusyo/kousei/17-2/.
14. 日本厚生劳动省. 平成27年度国民医疗费的概况. Available at: https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/15/index.html.
15. International Diabetes Federation. IDF diabetes atlas - 8th edition. Available at: http://www.diabetesatlas.org/across-the-globe.html.
16. 胡善联, 刘国恩, 许樟荣, 等. 我国糖尿病流行病学和疾病经济负担研究现状. 中国卫生经济, 2008, 27(8): 5-8.
17. 中国政府网. 2016年我国卫生和计划生育事业发展统计公报. Available at: http://www.nhfpc.gov.cn/guihuaxxs/s10748/201708/d82fa7141696407abb4ef764f3edf095.shtml?from=groupmessage&isappinstalled=1.
18. Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care, 1992, 15(7): 815-8199.
19. Porta M, Curletto G, Cipullo D, et al. Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence. Diabetes Care, 2014, 37(6): 1668-1674.
20. Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in Primary Care (ADDITION-Europe). Diabetes Care, 2015, 38(8): 1449-1455.

Chinese Journal of Evidence-Based Medicine

The evaluation of the economic burden caused by delay in the diagnosis and treatment for patients with diabetes mellitus based on Japanese Medical Big Data

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content